TOPIC: 2021 American Transplant Congress

Varicella Hepatitis Mimicking Immune Checkpoint Inhibitor-induced Liver Toxicity
M. J. Weiss¹, X. Zhang², E. K. Spengler¹
Versatile Strategy to Enhance Nanomedicine Delivery to Graft Endothelial Cells
C. Albert¹, L. G. Bracaglia¹, A. Koide², J. DiRito¹, T. Lysyy¹, C. Edwards¹, J. T. Langford¹, D. Haakinson¹, S. A. Hosgood³, M. L. Nicholson³, J. S. Pober¹, W. M. Saltzman¹, S. Kiode², G. Tietjen¹
Very Long-Term Patient and Kidney Allograft Outcomes in Kidney Transplant Recipients More Than 20 Years After Transplantation:
T. Schachtner, A. Reimann, T. Müller
Video Virtual Transplant Evaluation and Listing
V. Casingal¹, B. Thrasher², J. Brown², C. Fotiadis²
VO_2peak Differentiates Survival Post Kidney Transplant
H. Chakkera¹, B. Kaplan², P. Budhiraja¹, R. Butterfield¹
VP2 MRNA Distinguishes the Direct Injury and Inflammation Effects of Polyoma Virus (BK) Infection from the Cognate TCMR Response That Follows Immunosuppressive Minimization
P. F. Halloran¹, K. Famulski¹, K. S. Madill-Thomsen¹, G. Böhmig², G. Gupta³, M. Myślak⁴, O. Viklicky⁵, &. the INTERCOMEX Study Group⁶
Waitlist and Post-Transplant Outcomes of Candidates with Iabp or Ecmo: Comparison of Old and New Heart Allocation Policies
M. Colvin¹, Y. Ahn², S. Hall³, M. Skeans², M. Walsh⁴, A. Israni²
Waitlist and Post-Transplant Outcomes of Candidates With Lvad: Comparison of Old and New Heart Allocation Policies
M. Colvin¹, Y. Ahn², S. Hall³, M. Walsh⁴, A. Israni²
Waitlist Outcomes for Exception Candidates Following the Implementation of MMaT/250 Score
T. Ishaque¹, J. G. Wang¹, S. Karhadkar², D. Segev¹, A. B. Massie¹
Waitlist Outcomes for Patients with Hepatocellular Carcinoma Following the 2019 Exception Policy Change
K. Young¹, C. Enestvedt², W. Naugler¹, E. Maynard², A. Mitra¹, M. Wungiranirun¹, J. Jou¹, J. Ahn¹, M. Chang¹, D. Lhewa¹